A prospective clinical Brain-Gut natural history protocol has to date enrolled 97 participants of which 92 have completed the protocol. There are three measures of intestinal inflammation;fecal calprotectin, intestinal permeability, and serum cytokine IL-6 levels. Intestinal permeability is measured with the administration of a sugar based test solution which will be given orally to participants after an overnight fast. Excreted urine sugar ratios, expressed per m2 of body surface area measure gastrointestinal permeability. Serum IL-6 cytokine levels are measured via ELISA. Body mass and body fat analysis (plethysmography), intra-abdominal and liver ultrasound, and Fibroscan measures are collected. The intestinal permeability test solution was developed and tested and has been administered to 92 participants. The Gastrointestinal Pain Pointer (GIPP) is a technology that has been developed and beta tested, and validated at the Clinical Center of the NIH. The GIPP electronically gathers data on participants subjective location, type, and intensity of GI symptoms along with real-time synchronized objective measures of heart rate and blood pressure. The patient uses a graphical interface to choose their gender and body type, record the location and intensity of the GI distress, and selects descriptive words for the GI discomfort. This study found the GIPP to be a valid and reliable instrument thereby allowing clinicians to have a more integrated resource for pain assessment that includes location, intensity, and quality along with physiologic parameters (ref. 3) Recent findings include differential genetic expression in patients with differing digestive disorder symptoms (ref. 1, 5). An upregulation of the gene coding the pro-inflammatory cytokine IL-1a suggests that the mechansim behind stress-related changed in gastrointestinal symptoms is pro-inflammatory in nature (ref 4.) Additional findings were published regarding symptom distress in other comorbid digestive diseases including fatty liver disease. A structural equation model for patients with liver disease co-morbidities including HIV was tested, confirmed, and published (ref 2).

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
National Institute of Nursing Research
Zip Code
Heitkemper, Margaret M; Han, Claire Jungyoun; Jarrett, Monica E et al. (2016) Serum Tryptophan Metabolite Levels During Sleep in Patients With and Without Irritable Bowel Syndrome (IBS). Biol Res Nurs 18:193-8
Hardy, Theresa M; McCarthy, Donna O; Fourie, Nicolaas H et al. (2016) Anti-Müllerian Hormone Levels and Urinary Cortisol in Women With Chronic Abdominal Pain. J Obstet Gynecol Neonatal Nurs 45:772-780
Sherwin, LeeAnne B; Leary, Emily; Henderson, Wendy A (2016) Effect of Illness Representations and Catastrophizing on Quality of Life in Adults With Irritable Bowel Syndrome. J Psychosoc Nurs Ment Health Serv 54:44-53
Fourie, Nicolaas H; Wang, Dan; Abey, Sarah K et al. (2016) The microbiome of the oral mucosa in irritable bowel syndrome. Gut Microbes :1-16
Cong, Xiaomei; Xu, Wanli; Janton, Susan et al. (2016) Gut Microbiome Developmental Patterns in Early Life of Preterm Infants: Impacts of Feeding and Gender. PLoS One 11:e0152751
Weaver, Kristen R; Sherwin, LeeAnne B; Walitt, Brian et al. (2016) Neuroimaging the brain-gut axis in patients with irritable bowel syndrome. World J Gastrointest Pharmacol Ther 7:320-33
Cong, Xiaomei; Xu, Wanli; Romisher, Rachael et al. (2016) Gut Microbiome and Infant Health: Brain-Gut-Microbiota Axis and Host Genetic Factors. Yale J Biol Med 89:299-308
Henderson, Wendy A; Rahim-Williams, Bridgett; Kim, Kevin H et al. (2015) The Gastrointestinal Pain Pointer: A Valid and Innovative Method to Assess Gastrointestinal Symptoms. Gastroenterol Nurs :
Hardy, Theresa; McCarthy, Donnalee; Fourie, Nicolaas et al. (2015) The relationship of anti-Mullerian hormone levels and urine cortisol in women with chronic abdominal pain. Psychoneuroendocrinology 61:70
Del Valle-Pinero, Arseima Y; Sherwin, LeeAnne B; Anderson, Ethan M et al. (2015) Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis. World J Gastroenterol 21:155-63

Showing the most recent 10 out of 25 publications